0001140361-22-020274.txt : 20220523
0001140361-22-020274.hdr.sgml : 20220523
20220523165851
ACCESSION NUMBER: 0001140361-22-020274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sooch Mina
CENTRAL INDEX KEY: 0001674006
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34079
FILM NUMBER: 22952538
MAIL ADDRESS:
STREET 1: 17199 N. LAUREL PARK DRIVE
STREET 2: SUITE 401
CITY: LIVONIA
STATE: MI
ZIP: 48152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ocuphire Pharma, Inc.
CENTRAL INDEX KEY: 0001228627
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113516358
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
BUSINESS PHONE: 248-681-9815
MAIL ADDRESS:
STREET 1: 37000 GRAND RIVER AVE.
STREET 2: SUITE 120
CITY: FARMINGTON HILLS
STATE: MI
ZIP: 48335
FORMER COMPANY:
FORMER CONFORMED NAME: REXAHN PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20050516
FORMER COMPANY:
FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC
DATE OF NAME CHANGE: 20030423
4
1
form4.xml
FORM 4
X0306
4
2022-05-19
0001228627
Ocuphire Pharma, Inc.
OCUP
0001674006
Sooch Mina
C/O OCUPHIRE PHARMA, INC.
37000 GRAND RIVER AVE, SUITE 120
FARMINGTON HILLS
MI
48335
true
true
President and CEO
Common Stock
2022-05-19
4
P
0
12500
2.0703
A
412522
D
Common Stock
2022-05-20
4
P
0
12500
2.024
A
425022
D
The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.045 to $2.10. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
The price represents the weighted average price of the multiple transactions reported on this line. The shares were purchased at prices ranging from $2.015 to $2.025. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
/s/ Emily J. Johns, by Power of Attorney
2022-05-23